Date: Jan 5, 2020
Location: Houston, TX, US
Expected Travel: More than 50%
Requisition ID: 1743
About Teleflex Incorporated
Teleflex is a global provider of clinically effective medical technologies designed to improve the health and quality of people's lives. We apply purpose driven innovation a relentless pursuit of identifying unmet clinical needs to benefit patients and healthcare providers.
Our portfolio is diverse, with solutions in the fields of vascular and interventional access, interventional cardiology, surgical, anesthesia, cardiac care, interventional urology, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Interventional Urology NeoTract is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. As part of the Teleflex Interventional Urology business unit, NeoTract's initial focus is on improving the standard of care for patients with benign prostatic hyperplasia (BPH) using the UroLift System, a minimally invasive, permanent implant system that treats symptoms while preserving normal sexual function1.
The FDA-cleared UroLift System is clinically proven to treat lower urinary tract symptoms due to BPH. The UroLift System lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
More than 100,000 men worldwide have been treated with the UroLift System, which is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Join a dynamic, growing team that offers healthcare providers an array of medical technology solutions that make a difference in patients' lives. 1 *No instances of new, sustained erectile or ejaculatory dysfunction. McVary; Roehrborn, J Urology 2013 LIFT Study.